Servicio de Otorrinolaringología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.
Servicio de Cirugía Plástica. Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Acta Otorrinolaringol Esp (Engl Ed). 2024 May-Jun;75(3):169-176. doi: 10.1016/j.otoeng.2023.07.005. Epub 2024 Jan 13.
Out of all cutaneous squamous cell carcinomas originating in the head and neck (HNCSCC), 2-4% are associated with parotid or cervical lymph node metastasis. The aim of this study is to analyse the prognostic factors of patients with HNCSCC with lymph node involvement treated surgically. Additionally, we aim to compare the prognostic capacity of the classification of these patients according to the 8th edition of the TNM, and an alternative classification proposed by O'Brien et al. PATIENTS AND METHODS: Retrospective review of 65 patients with HNCSCC with lymph node metastasis treated surgically during the period 2000-2020.
During the study period we carried out 13 neck dissections and 52 parotidectomies + neck dissection in patients with lymph node metastases from a HNCSCC. The great majority of patients (89.2%) received post-operative radiotherapy. The 5 year disease-specific survival was 69.9%, and the overall survival it was 42.8%. The classification proposed by O'Brien et al., based on the parotid or cervical location of the lymph node metastases, and the size and number of the metastatic lymph nodes, had a better prognostic capacity than the TNM classification.
The surgical treatment of lymph node metastases in patients with HNCSCC achieved a high disease control. The classification based on the location, size and number of lymph node metastases proposed by O'Brien et al had better prognostic capacity than the TNM classification.
在所有起源于头颈部的皮肤鳞状细胞癌(HNCSCC)中,有 2-4%与腮腺或颈部淋巴结转移有关。本研究旨在分析接受手术治疗的伴有淋巴结受累的 HNCSCC 患者的预后因素。此外,我们旨在比较这些患者根据第 8 版 TNM 分类和 O'Brien 等人提出的替代分类的预后能力。
回顾性分析了 2000 年至 2020 年间接受手术治疗的 65 例伴有淋巴结转移的 HNCSCC 患者。研究期间,我们对 13 例颈部清扫术和 52 例腮腺切除术+颈部清扫术患者进行了治疗。大多数患者(89.2%)接受了术后放疗。5 年疾病特异性生存率为 69.9%,总生存率为 42.8%。O'Brien 等人提出的基于淋巴结转移的腮腺或颈部位置、转移淋巴结的大小和数量的分类,比 TNM 分类具有更好的预后能力。
手术治疗 HNCSCC 患者的淋巴结转移可实现较高的疾病控制率。基于淋巴结转移的位置、大小和数量的分类比 TNM 分类具有更好的预后能力。